Critical observers have known it for a long time, but the WHO is now also publicly admitting that because there is no data on the effectiveness of the monkeypox vaccine, all vaccinates are also part of a clinical study. Vaccination with the smallpox vaccine Imvanex is already underway in Europe – have the vaccinated people been informed beforehand?
On Saturday, the WHO held a press conference led by WHO Director-General Tedros Adhanom Ghebreyesus to warn the world about the monkeypox outbreak. That day he also overruled the expert committee to declare a global health emergency over this disease. This is despite the fact that the disease is mainly spread through sexual intercourse and especially within the homosexual scene.
Tim Nguyen, head of unit for global threats of infection at the World Health Organization’s emergency response programme, said the vaccine’s effectiveness was not yet known because it had never been used on this scale. “I want to underline one thing that is very important for WHO. We are not sure about the effectiveness of these vaccines as they have never been used in this context and on this scale”, warned Tim Nguyen. Report24 has already reported on this fact several times (see here or here): It can almost be considered a miracle that the WHO now also admits this fact.
Nguyen warned that everyone who receives the monkeypox vaccine is technically taking part in a “clinical study” to determine the vaccine’s effectiveness. “When these vaccines are given, it is through clinical trials and the prospective collection of data to improve our understanding of how effective these vaccines are,” he said. So basically we’re talking about turning the vaccinees into guinea pigs for big pharma.
The WHO also stated that the vast majority of cases of the disease occur in gay and bisexual men. Meanwhile, the EU Commission approved the monkeypox vaccine Imvanex from the German-Danish manufacturer Bavarian Nordic for monkeypox prevention authorized. Since 2013, this has also been approved for the prevention of a conventional smallpox disease. The approval for monkeypox is new – and of course not based on a comprehensive database.
The problem is that the package insert for the vaccine already lists around 50 side effects, including serious ones, as Report24 already reported. Breathing problems, dizziness and swelling of the neck and face can also occur here. Even with this experimental vaccine, however, further side effects and potential consequential damage could only become known in the course…